EP3840831A4 - Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment - Google Patents
Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment Download PDFInfo
- Publication number
- EP3840831A4 EP3840831A4 EP19852909.1A EP19852909A EP3840831A4 EP 3840831 A4 EP3840831 A4 EP 3840831A4 EP 19852909 A EP19852909 A EP 19852909A EP 3840831 A4 EP3840831 A4 EP 3840831A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- inflammatory bowel
- bowel disease
- high risk
- identifying individuals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Microbiology (AREA)
- Evolutionary Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Data Mining & Analysis (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862720468P | 2018-08-21 | 2018-08-21 | |
PCT/US2019/047231 WO2020041287A1 (en) | 2018-08-21 | 2019-08-20 | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3840831A1 EP3840831A1 (en) | 2021-06-30 |
EP3840831A4 true EP3840831A4 (en) | 2022-05-11 |
Family
ID=69591310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19852909.1A Pending EP3840831A4 (en) | 2018-08-21 | 2019-08-20 | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3840831A4 (en) |
AU (1) | AU2019325238A1 (en) |
CA (1) | CA3108719A1 (en) |
WO (1) | WO2020041287A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110045476A1 (en) * | 2009-04-14 | 2011-02-24 | Prometheus Laboratories Inc. | Inflammatory bowel disease prognostics |
US20120171672A1 (en) * | 2009-04-14 | 2012-07-05 | Prometheus Laboratories Inc. | Inflammatory bowel disease prognostics |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879553B2 (en) * | 2008-03-14 | 2011-02-01 | Exagen Diagnostics, Inc. | Biomarkers for inflammatory bowel disease and irritable bowel syndrome |
WO2012037199A2 (en) * | 2010-09-14 | 2012-03-22 | The Johns Hopkins University | Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles |
AU2012325798B2 (en) * | 2011-10-21 | 2015-11-26 | Société des Produits Nestlé S.A. | Methods for improving inflammatory bowel disease diagnosis |
WO2014182689A1 (en) * | 2013-05-06 | 2014-11-13 | Yacyshyn Bruce R | Method of using biomarkers in predicting inflammatory bowel disease |
US10295527B2 (en) * | 2016-03-14 | 2019-05-21 | Bruce Yacyshyn | Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis |
-
2019
- 2019-08-20 WO PCT/US2019/047231 patent/WO2020041287A1/en active Search and Examination
- 2019-08-20 EP EP19852909.1A patent/EP3840831A4/en active Pending
- 2019-08-20 CA CA3108719A patent/CA3108719A1/en active Pending
- 2019-08-20 AU AU2019325238A patent/AU2019325238A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110045476A1 (en) * | 2009-04-14 | 2011-02-24 | Prometheus Laboratories Inc. | Inflammatory bowel disease prognostics |
US20120171672A1 (en) * | 2009-04-14 | 2012-07-05 | Prometheus Laboratories Inc. | Inflammatory bowel disease prognostics |
Non-Patent Citations (1)
Title |
---|
MORTENSEN JOACHIM HØG ET AL: "Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis", JOURNAL OF CROHN'S AND COLITIS, vol. 9, no. 10, 18 July 2015 (2015-07-18), NL, pages 863 - 872, XP055907377, ISSN: 1873-9946, Retrieved from the Internet <URL:https://watermark.silverchair.com/jjv123.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAuAwggLcBgkqhkiG9w0BBwagggLNMIICyQIBADCCAsIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMzlRioibu2SG_AjSQAgEQgIICkychmHOXI4bIXNIYHuD5tuNT__UAlhuhR8PZjY7gI7o-RWwR4EpdLYCym14YZC_DExTXJtjw0prrXSo88LeV4tO1llfYC> DOI: 10.1093/ecco-jcc/jjv123 * |
Also Published As
Publication number | Publication date |
---|---|
WO2020041287A1 (en) | 2020-02-27 |
CA3108719A1 (en) | 2020-02-27 |
AU2019325238A1 (en) | 2021-03-18 |
EP3840831A1 (en) | 2021-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3836832A4 (en) | Patient-specific surgical method and system | |
EP3740274A4 (en) | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation | |
GB201804895D0 (en) | System and method for identifying at least one association of entity | |
EP3784112A4 (en) | Method and system for disease analysis and interpretation | |
EP3930455A4 (en) | System and method for field treatment and monitoring | |
EP3871789A4 (en) | Exhaust treatment system and method | |
EP3743864A4 (en) | Process digitization system and method | |
EP3884497A4 (en) | System and method for assessing medical images | |
EP3851036A4 (en) | Diagnosis assistance system and method | |
EP3834203A4 (en) | Method and system for developing clinical trial protocols | |
EP3730460A4 (en) | Method for upgrading and expanding sewage biological treatment process | |
EP3852603A4 (en) | Endoscope cleaning and inspection system and method | |
EP3756195A4 (en) | System and method for processing ecg recordings from multiple patients for clinician overreading | |
EP3446749A4 (en) | Hot plasma disease treatment system and method of use thereof | |
EP3819912A4 (en) | System and method for disease diagnosis using neural network | |
EP3774785A4 (en) | Method of treating fibrotic disease | |
EP3888539A4 (en) | Inspection assisting method and inspection assisting system | |
EP3948721A4 (en) | System and method of identifying equivalents for task completion | |
EP3602041A4 (en) | Methods for diagnosing and treating inflammatory bowel disease | |
EP3925711A4 (en) | Waste treatment system and waste treatment method | |
EP3804759A4 (en) | Method for treating and/or preventing regnase-1-related disease | |
EP3811400A4 (en) | System and method for self-cleaning wet treatment process | |
EP4010487A4 (en) | System and method for risk assessment of parkinsons disease | |
EP3953026A4 (en) | System and method for water treatment | |
EP3817746A4 (en) | Compounds for treatment of inflammatory bowel disease and methods thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210317 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220411 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/68 20060101ALI20220405BHEP Ipc: G01N 33/53 20060101ALI20220405BHEP Ipc: G01N 33/48 20060101ALI20220405BHEP Ipc: C12Q 1/68 20180101ALI20220405BHEP Ipc: A61P 1/00 20060101AFI20220405BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230207 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20240103 |